The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLX.L Regulatory News (FLX)

  • There is currently no data for FLX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing and Early Redemption of Loan Note

3 Oct 2016 07:00

RNS Number : 4527L
Falanx Group Limited
03 October 2016
 

Falanx Group Limited ("Falanx" or "the Company")

Placing of £0.75 million

and

Early Redemption of Loan Note

 

Falanx Group (AIM:FLX) announces on 3rd October 2016 the placing ("Placing") of new ordinary shares of no par value in the capital of the Company ("Ordinary Shares") raising total gross proceeds of £0.75 million and the immediate repayment of senior unsecured zero coupon convertible loan notes ("Loan Notes").

 

Placing

 

On 30 Sept 2016, Falanx agreed to place 18,750,000 of new Ordinary Shares following an unsolicited approach by Turner Pope Investments on behalf of their clients, at a price of 4 pence per Ordinary Share, raising gross proceeds of £750,000. No Warrants are attached to this Placing. Turner Pope Investments will receive 468,750 Ordinary Shares as Fees, which are subject to a 6 month 'Lock-in' period from the date of issue.

 

The total Ordinary Shares to be issued pursuant to the Placing represent approximately 18.20% of the Company's existing issued share capital and will represent, in aggregate, approximately 15.4% of the Company's enlarged issued share capital.

 

Early Redemption of Loan Notes

 

Falanx will use proceeds from the Placing to fund the redemption of the Loan Notes issued to Darwin Capital Limited on 5 May 2016 and provide further working capital for the Company.

 

The Loan Notes, which carry a fixed and floating senior charge over the assets of the Company, fall due for redemption on 5 November 2016 ("Redemption Date") in the sum of £495,000 ("Principal Amount") will be redeemed immediately in cash.

 

Repayment of Loan Notes - further terms

 

Under the term of the loan, the Company can redeem the Loan Notes for cash at any time prior to the Redemption Date of 5 November 2016, in which case the Company may elect to cancel or enforce exercise of half of the Warrants issued to the Loan Note Holder.

 

The Company has elected, under these terms, to cancel half of the Warrants issued to the Loan Note Holder.

 

Admission of the new Ordinary Shares to trading on AIM

Application will be made for admission of the 19,218,750 new Ordinary Shares to be issued pursuant to the Placing to trading on the AIM Market of the London Stock Exchange, which is expected to take place on or around 8.00 a.m. on 10th October 2016 ("Admission"). The Placing is conditional on Admission becoming effective. The new Ordinary Shares will, when issued, be credited as fully paid and will rank equally in all respects with the existing Ordinary Shares, including the right to receive any dividend or other distribution declared, made or paid after Admission.

Following Admission, the Company's enlarged issued share capital will comprise 124,830,904 Ordinary Shares carrying one vote per share. The Company does not hold any Ordinary Shares in treasury.

Chairman of Falanx, Mike Read said:

 

"I am delighted to announce this placing at the market price and the repayment of the convertible loan. We are grateful to Darwin Capital Limited for providing the loan to assist us in the acquisition of ASC. When Turner Pope Investments approached the company the Board felt the timing was right to repay the loan and move the business forward on a debt free basis."

Falanx's CEO, John Blamire said:

 

"Receiving an unsolicited approach to invest in Falanx at the market price and without the requirement for incentives such as Warrants or discounts, provides further proof Falanx has turned the corner as a highly investible business and Cyber Security is an extremely attractive growth area".

Turner Pope Investments, Director, Ben Turner said:

"We have been observing Falanx for some time and have historically invested in other successful companies under the stewardship of Mike Read. Our clients were keen to attain an equity holding in Falanx but were unable to make the level of investment they required through the secondary market and so we decided to approach the company directly. We are extremely pleased Falanx have accepted our offer and our shareholders look forward to supporting the growth of this exciting company"

 

Enquiries:

 

Falanx Group Limited

John Blamire, Chief Executive

www.falanxgroup.com

www.falanxassuria.com

www.falanxcyberdefence.com

+ 44 (0) 20 7856 9457 

Panmure Gordon (UK) Limited

Nominated Adviser & Broker

+44 (0) 20 7886 2500

Andrew Godber / Peter Steel

Falanx Group Limited, is a global intelligence, security and cyber defence provider working with blue chip and government clients. The Group listed on AIM in June 2013 under ticker FLX For more information: http://www.falanxgroup.com/

Notes to Editors

§ Falanx Group Limited, is a global intelligence, security and cyber defence provider working with blue chip and government clients.

 

§ The Group listed on AIM in June 2013 under ticker FLX.

 

§ For more information: http://www.falanxgroup.com/

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRUUAURNUARRUA
Date   Source Headline
9th Dec 20222:42 pmRNSHolding(s) in Company
8th Dec 20224:29 pmRNSResult of AGM
8th Dec 20227:00 amRNSInterim Results
24th Nov 20225:17 pmRNSHolding(s) in Company
15th Nov 20225:56 pmRNSNotice of AGM
18th Oct 20227:00 amRNSDirectorate Change
29th Sep 20227:00 amRNSFinal Results
20th Sep 20227:00 amRNSHolding(s) in Company
5th Sep 20224:53 pmRNSHolding(s) in Company
4th Aug 20222:06 pmRNSSecond Price Monitoring Extn
4th Aug 20222:00 pmRNSPrice Monitoring Extension
4th Aug 202211:05 amRNSSecond Price Monitoring Extn
4th Aug 202211:00 amRNSPrice Monitoring Extension
4th Aug 20227:00 amRNSTrading Update
9th May 20227:00 amRNSPartnership to Provide M-EDR to UK Customers
8th Apr 20224:06 pmRNSHolding(s) in Company
6th Apr 202211:59 amRNSHolding(s) in Company
1st Apr 20227:00 amRNSChange of Adviser
30th Mar 20222:44 pmRNSDirector/PDMR Shareholding
23rd Mar 202212:59 pmRNSDirector/PDMR Shareholding
10th Feb 202211:11 amRNSDirector/PDMR Shareholding
24th Jan 20227:00 amRNSDirector/PDMR Shareholding
19th Jan 20225:20 pmRNSHolding(s) in Company
19th Jan 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 202111:14 amRNSResult of AGM
7th Dec 20217:00 amRNSInterim Results
16th Nov 20212:10 pmRNSNotice of AGM
29th Oct 20211:57 pmRNSExercise of Options, TVR and PDMR dealing
27th Oct 20219:03 amRNSDirector/PDMR Shareholding
26th Oct 20217:00 amRNSDirector/PDMR Shareholding
25th Oct 20213:25 pmRNSExercise of Options and TVR
13th Oct 202111:06 amRNSSecond Price Monitoring Extn
13th Oct 202111:00 amRNSPrice Monitoring Extension
13th Oct 20217:00 amRNSTrading update and BOOST&Co loan facility update
6th Oct 20214:41 pmRNSSecond Price Monitoring Extn
6th Oct 20214:35 pmRNSPrice Monitoring Extension
6th Oct 20212:43 pmRNSSale of Assynt for £4.6 million
4th Oct 20217:00 amRNSFalanx Launch Mass Market Security Assessment Tool
29th Sep 20217:00 amRNSAnnual results for the year ended 31 March 2021
18th Aug 20217:01 amRNSGrant of share options
18th Aug 20217:00 amRNSTrading Update & New Loan Facility
9th Jul 20219:07 amRNSHolding(s) in Company
29th Apr 20217:00 amRNSCancellation of unapproved Share Options
1st Apr 20217:00 amRNSIssue of Equity and TVR
26th Feb 20213:31 pmRNSResult of GM
10th Feb 20212:03 pmRNSPublication of Circular & Notice of GM
8th Feb 202111:05 amRNSSecond Price Monitoring Extn
8th Feb 202111:00 amRNSPrice Monitoring Extension
5th Feb 20217:00 amRNSContract Wins and Covid Business Interruption Loan
18th Jan 20212:06 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.